BRK-B vs EVG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
EVG presents as a deep-value play with a stable Piotroski F-Score of 6/9, trading significantly below both its Graham Number ($16.79) and Intrinsic Value ($32.45). While the fund exhibits strong profitability metrics and a highly attractive 8.20% dividend yield, it is hampered by negative revenue growth (-11%) and a completely bearish technical trend (0/100). The disconnect between the fundamental value and the market price suggests a value trap risk or a significant lag in market recognition. Overall, the stability of the balance sheet is offset by poor momentum and declining top-line growth.
Compare Another Pair
Related Comparisons
BRK-B vs EVG: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Eaton Vance Short Duration Diversified Income Fund (EVG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.